Apple Polyphenol Extract Improves High-Fat Diet-Induced Hepatic Steatosis by Regulating Bile Acid Synthesis and Gut Microbiota in C57BL/6 Male Mice

被引:53
作者
Li, Deming [1 ]
Cui, Yuan [1 ]
Wang, Xinjing [1 ]
Liu, Fang [1 ]
Li, Xinli [1 ,2 ]
机构
[1] Soochow Univ, Sch Publ Hlth, Med Coll, Suzhou 215123, Jiangsu, Peoples R China
[2] Soochow Univ, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou 215123, Jiangsu, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
apple polyphenol extract; hepatic steatosis; bile acid metabolism; FXR; gut microbiota; FARNESOID-X-RECEPTOR; LIVER-DISEASE; METABOLISM; INFLAMMATION; CHOLESTEROL; IMPACT; EPIDEMIOLOGY; PREVALENCE; EXPRESSION; MECHANISM;
D O I
10.1021/acs.jafc.1c02532
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Our previous study showed that apple polyphenol extract (APE) ameliorated high-fat diet-induced hepatic steatosis in CS7BL/6 mice by targeting the LKB1/AMPK pathway; to investigate whether other mechanisms are involved in APE induction of improved hepatic steatosis, especially the roles of bile acid (BA) metabolism and gut microbiota, we conducted this study. Thirty-three C57BL/6 male mice were fed with high-fat diet for 12 weeks and concomitantly treated with sterilized water (CON) or 125 or 500 mg/(kg.bw.day) APE (low-dose APE, LAP; high-dose APE, HAP) by intragastric administration. APE treatment decreased total fecal BA contents, especially fecal primary BA levels, mainly including cholic acid, chenodeoxycholic acid, and muricholic acid. An upregulated hepatic Farnesoid X receptor (FXR) protein level and downregulated protein levels of cholesterol 7 alpha-hydroxylase (CYP7A1) and cholesterol 7 alpha-hydroxylase (CYP27A1) were observed after APE treatment, which resulted in the suppressed BA synthesis. Meanwhile, APE had no significant effects on mucosal injury and FXR expression in the jejunum. APE regulated the diversity of gut microbiota and microbiota composition, characterized by significantly increased relative abundance of Akkermansia and decreased relative abundance of Lactobacillus. Furthermore, APE might affect the reverse cholesterol transport in the ileum, evidenced by the changed mRNA levels of NPC1-like intracellular cholesterol transporter 1 (Npc1l1), liver X receptor (Lxr), ATP binding cassette subfamily A member 1 (Abca1), and ATP binding cassette subfamily G member 1 (Abcg1). However, APE did not affect the dihydroxylation and taurine metabolism of BA. The correlation analysis deduced no obvious interactions between BA and gut microbiota. In summary, APE, especially a high dose of APE, could alleviate hepatic steatosis, and the mechanisms were associated with inhibiting BA synthesis and modulating gut microbiota.
引用
收藏
页码:6829 / 6841
页数:13
相关论文
共 73 条
[1]   Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption [J].
Altmann, SW ;
Davis, HR ;
Zhu, LJ ;
Yao, XR ;
Hoos, LM ;
Tetzloff, G ;
Iyer, SPN ;
Maguire, M ;
Golovko, A ;
Zeng, M ;
Wang, LQ ;
Murgolo, N ;
Graziano, MP .
SCIENCE, 2004, 303 (5661) :1201-1204
[2]   Triglyceride Metabolism in the Liver [J].
Alves-Bezerra, Michele ;
Cohen, David E. .
COMPREHENSIVE PHYSIOLOGY, 2018, 8 (01) :1-22
[3]   Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice [J].
Anhe, Fernando F. ;
Nachbar, Renato T. ;
Varin, Thibault V. ;
Trottier, Jocelyn ;
Dudonne, Stephanie ;
Le Barz, Melanie ;
Feutry, Perrine ;
Pilon, Genevieve ;
Barbier, Olivier ;
Desjardins, Yves ;
Roy, Denis ;
Marette, Andre .
GUT, 2019, 68 (03) :453-464
[4]   A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice [J].
Anhe, Fernando F. ;
Roy, Denis ;
Pilon, Genevieve ;
Dudonne, Stephanie ;
Matamoros, Sebastien ;
Varin, Thibault V. ;
Garofalo, Carole ;
Moine, Quentin ;
Desjardins, Yves ;
Levy, Emile ;
Marette, Andre .
GUT, 2015, 64 (06) :872-883
[5]   Procyanidin Dimers Are Metabolized by Human Microbiota with 2-(3,4-Dihydroxyphenyl)acetic Acid and 5-(3,4-Dihydroxyphenyl)-γ-valerolactone as the Major Metabolites [J].
Appeldoorn, Maaike M. ;
Vincken, Jean-Paul ;
Aura, Anna-Marja ;
Hollman, Peter C. H. ;
Gruppen, Harry .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2009, 57 (03) :1084-1092
[6]   Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice [J].
Bae, Jin-Sik ;
Park, Jong-Min ;
Lee, Junghoon ;
Oh, Byung-Chul ;
Jang, Sang-Ho ;
Lee, Yun Bin ;
Han, Young-Min ;
Ock, Chan-Young ;
Cha, Ji-Young ;
Hahm, Ki-Baik .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 66 :32-44
[7]   BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis [J].
Carino, Adriana ;
Cipriani, Sabrina ;
Marchiano, Silvia ;
Biagioli, Michele ;
Santorelli, Chiara ;
Donini, Annibale ;
Zampella, Angela ;
Monti, Maria Chiara ;
Fiorucci, Stefano .
SCIENTIFIC REPORTS, 2017, 7
[8]   The gut microbiota: A key factor in the therapeutic effects of (poly) phenols [J].
Carlos Espin, Juan ;
Gonzalez-Sarrias, Antonio ;
Tomas-Barberan, Francisco A. .
BIOCHEMICAL PHARMACOLOGY, 2017, 139 :82-93
[9]   Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease [J].
Chavez-Talavera, Oscar ;
Tailleux, Anne ;
Lefebvre, Philippe ;
Staels, Bart .
GASTROENTEROLOGY, 2017, 152 (07) :1679-+
[10]   Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes [J].
Chen, Lihong ;
Yao, Xiaozhou ;
Young, Andrew ;
McNulty, Judi ;
Anderson, Don ;
Liu, Yaping ;
Nystrom, Christopher ;
Croom, Dallas ;
Ross, Sean ;
Collins, Jon ;
Rajpal, Deepak ;
Hamlet, Kimberly ;
Smith, Chari ;
Gedulin, Bronislava .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2012, 302 (01) :E68-E76